141 related articles for article (PubMed ID: 2985632)
1. 1 alpha, 25-dihydroxyvitamin D3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line.
Franceschi RT; James WM; Zerlauth G
J Cell Physiol; 1985 Jun; 123(3):401-9. PubMed ID: 2985632
[TBL] [Abstract][Full Text] [Related]
2. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
Dokoh S; Donaldson CA; Haussler MR
Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
[TBL] [Abstract][Full Text] [Related]
4. [Correlation between the concentration of 1,25 alpha dihydroxyvitamin D3 receptors and growth inhibition, and differentiation of human osteosarcoma cells induced by vitamin D3].
Tokuumi Y
Nihon Seikeigeka Gakkai Zasshi; 1995 Apr; 69(4):181-90. PubMed ID: 7782656
[TBL] [Abstract][Full Text] [Related]
5. 1 alpha,25-Dihydroxyvitamin D3 rapidly increases nuclear calcium levels in rat osteosarcoma cells.
Sorensen AM; Bowman D; Baran DT
J Cell Biochem; 1993 Jun; 52(2):237-42. PubMed ID: 8396151
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a human osteoblastic osteosarcoma cell line (SAOS-2) with high bone alkaline phosphatase activity.
Murray E; Provvedini D; Curran D; Catherwood B; Sussman H; Manolagas S
J Bone Miner Res; 1987 Jun; 2(3):231-8. PubMed ID: 2843003
[TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition.
Shabahang M; Buras RR; Davoodi F; Schumaker LM; Nauta RJ; Evans SR
Cancer Res; 1993 Aug; 53(16):3712-8. PubMed ID: 8393379
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.
Shabahang M; Buras RR; Davoodi F; Schumaker LM; Nauta RJ; Uskokovic MR; Brenner RV; Evans SR
Cancer Res; 1994 Aug; 54(15):4057-64. PubMed ID: 8033137
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines.
Evans SR; Houghton AM; Schumaker L; Brenner RV; Buras RR; Davoodi F; Nauta RJ; Shabahang M
J Surg Res; 1996 Feb; 61(1):127-33. PubMed ID: 8769954
[TBL] [Abstract][Full Text] [Related]
10. Effects of vitamin D metabolites and bisphosphonates on fibronectin release from monocyte-derived macrophages.
Mian M; Adami S; Rigo A; Bonazzi L; Braga V; Lo Cascio V
Int J Tissue React; 1991; 13(3):139-43. PubMed ID: 1835718
[TBL] [Abstract][Full Text] [Related]
11. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
Levy Y; Knutson JC; Bishop C; Shany S
Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403
[TBL] [Abstract][Full Text] [Related]
12. 1 alpha,25-Dihydroxyvitamin D3 induces anchorage-independent growth and c-Ki-ras expression of BALB/3T3 and NIH/3T3 cells.
Huh N; Satoh M; Nose K; Abe E; Suda T; Rajewsky MF; Kuroki T
Jpn J Cancer Res; 1987 Feb; 78(2):99-102. PubMed ID: 3030988
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid and glucocorticoids enhance the effect of 1,25-dihydroxyvitamin D3 on bone gamma-carboxyglutamic acid protein synthesis by rat osteosarcoma cells.
Nishimoto SK; Salka C; Nimni ME
J Bone Miner Res; 1987 Dec; 2(6):571-7. PubMed ID: 3484302
[TBL] [Abstract][Full Text] [Related]
14. Identification of the subdomain in the nuclear receptor for the hormonal form of vitamin D3, 1 alpha,25-dihydroxyvitamin D3, vitamin D receptor, that is covalently modified by an affinity labeling reagent.
Swamy N; Kounine M; Ray R
Arch Biochem Biophys; 1997 Dec; 348(1):91-5. PubMed ID: 9390178
[TBL] [Abstract][Full Text] [Related]
15. Biochemical significance of enhanced activity of fluorinated 1,25-dihydroxyvitamin D3 in human cultured cell lines.
Eisman JA; Frampton RJ; McLean FJ
Cell Biochem Funct; 1986 Apr; 4(2):115-22. PubMed ID: 3011306
[TBL] [Abstract][Full Text] [Related]
16. Induction of transforming growth factor-beta autocrine activity by all-trans-retinoic acid and 1 alpha,25-dihydroxyvitamin D3 in NRP-152 rat prostatic epithelial cells.
Danielpour D
J Cell Physiol; 1996 Jan; 166(1):231-9. PubMed ID: 8557772
[TBL] [Abstract][Full Text] [Related]
17. Regulation of expression of the cell adhesion receptors, integrins, by recombinant human interleukin-1 beta in human osteosarcoma cells: inhibition of cell proliferation and stimulation of alkaline phosphatase activity.
Dedhar S
J Cell Physiol; 1989 Feb; 138(2):291-9. PubMed ID: 2521862
[TBL] [Abstract][Full Text] [Related]
18. Induction of anchorage-independent growth of JB6 mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3.
Hosoi J; Abe E; Suda T; Colburn NH; Kuroki T
Cancer Res; 1986 Nov; 46(11):5582-6. PubMed ID: 3019530
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties.
Rodan SB; Imai Y; Thiede MA; Wesolowski G; Thompson D; Bar-Shavit Z; Shull S; Mann K; Rodan GA
Cancer Res; 1987 Sep; 47(18):4961-6. PubMed ID: 3040234
[TBL] [Abstract][Full Text] [Related]
20. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
